Feasibility Test of Action Planning in Pediatric IBD

🩺 Protocol Summary

The goal of this interventional study is to test the feasibility of a new communication tool, call MyIBD, in youth ages 13 to 19 years with inflammatory bowel disease. The main question\[s\] it aims to answer are: * Is the MyIBD communication tool feasible to use in everyday clinical practice? * Does the MyIBD tool have potential to improve patients' self-management skills and the quality of care they receive? Participants who receive the MyIBD intervention will complete surveys about their care at three times points - at study enrollment, at 6 months, and at 12 months. The surveys will help the research team learn about the feasibility of using MyIBD in practice and about any effects on patients' self-management skills and quality of care. Researchers will compare those receiving a MyIBD document to a randomly selected control group (patients receiving usual care for pediatric inflammatory bowel disease) to see if self-management skills and quality of care differ between the groups.

Primary Research Facility: University of North Carolina-Chapel Hill School of Medicine (Chapel Hill, North Carolina)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Inflammatory Bowel Diseases?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 13 Years and 19 Years?

🔍 Protocol Specified Age Range: 13 Years to 19 Years

Able to attend required clinic visits at University of North Carolina-Chapel Hill School of Medicine (Chapel Hill, North Carolina)?

🔍 Logistical Requirement: Site at University of North Carolina-Chapel Hill School of Medicine

📍 Primary Site Map

Site: University of North Carolina-Chapel Hill School of Medicine — Chapel Hill, North Carolina

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.